{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T19:24:38Z","timestamp":1780687478409,"version":"3.54.1"},"reference-count":19,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Padjadjaran University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Cerebral vasospasm is the most common complication of subarachnoid hemorrhage (SAH) that is related to high mortality and morbidity. Early biomarkers predicting those conditions are still limited. This study aims to analyze spectrin degradation products (SBDPs) as potential biomarkers for SAH patients, which can be used to monitor clinical outcomes. Materials and Methods: We conducted a prospective observational study in acute SAH within 72 h of onset. All patients underwent placement of continuous cerebrospinal drainage, and liquor was taken four times and analyzed using ELISA to measure SBDP150, SBDP145, and SBDP120 levels and analyzed using Friedman test and post hoc Wilcoxon analysis. The relationship between SBDP levels and vasospasm, as well as functional outcomes (using the Glasgow Outcome Scale\u2013Extended, GOSE), was assessed. Results: We enrolled thirty-five patients: thirty patients with lumbar drainage (LD) and five with extra ventricular drainage (EVD). Friedman\u2019s analysis showed significant changes over time for SBDP120 (p = 0.0001) and SBDP145 (p = 0.0001), but not for SBDP150 (p = 0.218). Levels of SBDP120 on day 3 (p = 0.001), SBDP120 on day 5 (p = 0.022), and SBDP145 on day 3 (p = 0.005) in EVD group were higher than in the LD group. SBDP145 on day 5 was significantly higher in patients with vasospasm (p = 0.041 in all patients, p = 0.028 in LD patients), indicating its potential as an early biomarker for vasospasm. SBDP145 on day 7 (p = 0.014) is the strongest predictor of unfavorable GOSE at 90 days in all patients. In LD patients, SBDP145 on day 7 (p = 0.002), SBDP120 on day 7 (p = 0.009), and SBDP120 on day 10 (p = 0.043) were significantly associated with poor GOSE at 90 days. Conclusions: A higher level of SBDP145 on day 5 can predict vasospasm risk, while an elevated level of SBDP145 and SBDP120 on day 7 is a potential predictor of poor functional outcomes. SBDPs may serve as valuable biomarkers for SAH management.<\/jats:p>","DOI":"10.3390\/medicina61030454","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T11:20:57Z","timestamp":1741173657000},"page":"454","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Role of SBDP Protein as a Potential Biomarker for Early-Onset Subarachnoid Hemorrhagic"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2221-1207","authenticated-orcid":false,"given":"Ita M.","family":"Sari","sequence":"first","affiliation":[{"name":"Doctoral Program in Medical Sciences, Faculty of Medicine, Universitas Padjadjaran, Bandung 40161, Indonesia"},{"name":"National Brain Center Hospital Prof. Dr. dr. Mahar Mardjono, Jakarta 13630, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selfy","family":"Oswari","sequence":"additional","affiliation":[{"name":"Doctoral Program in Medical Sciences, Faculty of Medicine, Universitas Padjadjaran, Bandung 40161, Indonesia"},{"name":"National Brain Center Hospital Prof. Dr. dr. Mahar Mardjono, Jakarta 13630, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus A.","family":"Ong","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, Universitas Padjadjaran, Bandung 40161, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achmad","family":"Adam","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Faculty of Medicine, Universitas Padjadjaran, Bandung 40161, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5951-4733","authenticated-orcid":false,"given":"Nur","family":"Atik","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Bandung 40161, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"ref_1","unstructured":"Grotta, J.C., and Albers, G. (2015). Aneurysmal Subarachnoid Hemorrhage. Stroke: Pathophysiology, Diagnosis and Management, Elsevier."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pharmthera.2004.10.002","article-title":"Delayed cerebral vasospasm and nitric oxide: Review, new hypothesis, and proposed treatment","volume":"105","author":"Pluta","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12987-022-00312-4","article-title":"The blood-brain barrier and the neurovascular unit in subarachnoid hemorrhage: Molecular events and potential treatments","volume":"19","author":"Zamani","year":"2022","journal-title":"Fluids Barriers CNS"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/sj.jcbfm.9600283","article-title":"Mechanism of early brain injury after subarachnoid hemorrhage","volume":"26","author":"Cahill","year":"2006","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4103\/2394-8108.178546","article-title":"Biomarkers for acute diagnosis and management of stroke in neurointensive care units","volume":"2","author":"Glushakova","year":"2016","journal-title":"Brain Circ."},{"key":"ref_6","first-page":"737","article-title":"Choice for the Removal of Bloody Cerebrospinal Fluid in Post coiling AneurysmSubarachnoid Hemorrhage: External Ventricular Drainage or Lumbar Drainage","volume":"24","author":"Sun","year":"2014","journal-title":"Turk. Neurosurg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jocn.2019.04.010","article-title":"Safety and feasibility of lumbar drainage in the management of poor-grade aneurysmal subarachnoid hemorrhage","volume":"64","author":"Panni","year":"2019","journal-title":"J. Clin. Neurosci."},{"key":"ref_8","first-page":"238","article-title":"Spinal Cerebrospinal Fluid Drainage for prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage: A Prospective, Randomized controlled study","volume":"13","author":"Borkar","year":"2019","journal-title":"Asian J. Neurosurg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/jamaneurol.2023.1792","article-title":"Effectiveness of Lumbar Cerebrospinal Fluid Drain Among Patients with Aneurysmal Subarachnoid Hemorrhage","volume":"80","author":"Wolf","year":"2023","journal-title":"JAMA Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Das, A., and Dubreuil, R.R. (2009). Spectrin: Organization and Function in Neurons. Encyclopedia of Neuroscience, Elsevier.","DOI":"10.1016\/B978-008045046-9.00731-2"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3171\/JNS-07\/10\/0792","article-title":"\u03b1II\u2014Spectrin breakdown products in aneurysmal subarachnoid hemorrhage: A novel biomarker of proteolytic injury","volume":"107","author":"Lewis","year":"2007","journal-title":"J. Neurosurg."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Papa, L., Rosenthal, K., Silvestri, F., Axley, J.C., Kelly, J.M., and Lewis, S.B. (2018). Evaluation of alpha-II-spectrin breakdown products as potential biomarkers for early recognition and severity of aneurysmal subarachnoid haemorrhage. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-31631-y"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Siman, R., Giovannone, N., Toraskar, N., Frangos, S., Stein, S.C., Levine, J.M., and Kumar, M.A. (2011). Evidence that a Panel of Neurodegeneration Biomarkers Predicts Vasospasm, Infarction, and Outcome in Aneurysmal Subarachnoid Hemorrhage. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0028938"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1089\/neu.1998.15.573","article-title":"Structured Interviews for the Glasgow Outcome Scale and the Extended Glasgow Outcome Scale: Guidelines for Their Use","volume":"15","author":"Wilson","year":"1998","journal-title":"J. Neurotrauma"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0166-2236(99)01479-4","article-title":"Calpain and caspase: Can you tell the difference","volume":"23","author":"Wang","year":"2000","journal-title":"Trends Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/bc.bc_27_16","article-title":"Prospective clinical biomarkers of caspase-mediated apoptosis associated with neuronal and neurovascular damage following stroke and other severe brain jejas: Implications for chronic neurodegeneration","volume":"3","author":"Glushakova","year":"2017","journal-title":"Brain Circ."},{"key":"ref_17","first-page":"2437","article-title":"Regional calpain and caspase-3 proteolysis of \u03b1-spectrin after traumatic brain injury","volume":"9","author":"Pike","year":"1998","journal-title":"Neuro Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2013.08.010","article-title":"Quantitative Studies of Caspase-3 Catalyzed \u03b1II-Spectrin Breakdown","volume":"1533","author":"Witek","year":"2013","journal-title":"Brain Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e5140","DOI":"10.1097\/MD.0000000000005140","article-title":"Effect of the drainage of cerebrospinal fluid in patients with aneurysmal subarachnoid haemorrhage","volume":"95","author":"Qian","year":"2016","journal-title":"Medicine"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/3\/454\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:47:52Z","timestamp":1760028472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/3\/454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["medicina61030454"],"URL":"https:\/\/doi.org\/10.3390\/medicina61030454","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]}}}